Report Overview

The global expression vectors market was valued at US$ 335.78 million in 2021 and is expected to witness a CAGR of 6.35% during the forecast period.

Market Fundamentals

Expression vectors are cloning vectors with appropriate expression signals to provide the maximum level of gene expression. These often help introduce an important gene into a selected cell, further stimulating the cell's production of the protein encoded by the gene. Expression vectors are utilized in the production of therapeutics, continuously activated proteins for biophysical, biochemical, and structural research, and enormous protein quantities for industrial purposes. Furthermore, expression vectors are employed for producing antibodies, growth hormones, insulin, antibiotics, and vaccinations.

[79874934]

Market Dynamics

The global expression vectors market is showing high growth due to certain factors such as increasing demand for protein-based therapeutics, high incidence of lifestyle, hereditary, and infectious diseases, as well as expanding R&D activities as a result of soaring protein therapy investments. Increased market fragmentation, strict regulatory guidelines that support entry difficulties, and the high cost of protein treatments are the main factors limiting the market expansion. 

Market Ecosystem

The global expression vectors market has been analyzed from four perspectives: types, applications, end-use, and region. 

Expression Vectors Market by Type

[98348322]

According to types, the global expression vectors market is grouped into mammalian expression vectors, bacterial expression vectors, yeast expression vectors, and insect expression vectors. Among these, the bacterial expression vectors segment has dominated the market. Bacterial expression vectors are widely used due to their simple procedure and low cost, high expression yield, and thorough understanding of the system. The yeast expression vectors are characterized by being single cells with fast growth rates and easy gene therapy. Furthermore, since yeast is eukaryote, it has an intron excision mechanism that can produce and express eukaryotes' recombinant DNA. The mammalian expression segment is expected to witness high growth in the forecast period due to the mammalian host system's ability to synthesize recombinant proteins and folding. 

Expression Vectors Market by Application 

Based on application, the global expression vectors market is segmented into industrial applications, therapeutics applications, and research applications. Therapeutic applications have dominated the market. The high growth of the therapeutics segment is owing to increased cancer cases, which expression vectors can treat. The segment is expected to show high growth in the forecast period owing to rising therapeutic formulations on recombinant technology for treating metabolic disorders. Furthermore, over the forecast period, the use of expression vectors in the research and development of biomedical and biopharmaceutical products is also anticipated to positively affect the expression vectors market growth. 

Expression Vectors Market by End-user 

The market is grouped into academic research, pharmaceutical and biotechnology companies, and research applications based on end-user. Pharmaceutical and biotechnology companies have dominated the market.  Biotechnology and pharmaceutical companies segment have covered most of the market due to advancements in recombinant DNA technology to manufacture innovative drugs and pharmaceutical proteins. Furthermore, it is anticipated that academic research organizations will experience rapid expansion due to increased research activities in various fields in the upcoming years.

Expression Vectors Market by Region

geographically, the global expression vectors market has been segmented into North America, Europe, Asia Pacific, and the rest of the world.  North America dominates the global market due to increased scientific research and the development of novel technology in this area. Additionally, the growth of this market is indirectly driven by rising government and private sector investment in synthetic biology research in the United States. The Asia Pacific market is expected to grow in the forecast period due to rapid expansion of pharmaceutical & biotechnology companies in the region. Furthermore, increasing advanced healthcare systems in the region and high demand for new and effective treatment drugs boost market growth. 

 Competitive Landscape

Some prominent players operating in the global expression vectors market are:

• Promega Corporation
• Bio-Rad Laboratories, Inc. 
• Merck Millipore Ltd. 
• QIAGEN NV 
• DNA 2.O, Inc.
• New England Biolabs Inc. 
• Sigma-Aldrich Corporation 
• GenScript USA Inc. 
• Agilent Technologies, Inc. 
• Thermo Fisher Scientific, Inc. 

Frequently Asked Questions About This Report